HealthQuill Biotech
Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with diabetic peripheral neuropathy has yielded positive results.
Drugs Medical Pharma

Venture capitalists, scientists plan biomedical research unit for new drugs

HQ Team January 13, 2024: High-profile scientists and financiers are pooling resources to launch a biomedical research facility that they claim will offer.

Read More
Merck acquisition
Drugs Pharma

Merck acquires Imago BioSciences for $1.35 billion

Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.

Read More